Synthetic Biology Market Regional Analysis

Geographically, the synthetic biology market is leading in North America owing to several factors like robust research and development architecture. Mainly, Canada and the United States holds a strong infrastructure for research and development. This comprises top-class universities, research institutes, and biotech companies that fuel inventions and advances in the domain of synthetic biology. Moreover, growing funding and heavy investments in synthetic biology and biotechnology from both public and private sectors aid better research and development of technologies in the region. The leading vendors operating in North America include Thermo Fisher Scientific, Agilent Technologies, Ginkgo Bioworks, and Amyris, Inc. among others. 

The market in Asia-Pacific is observed to be the fastest growing due to speedy economic growth and expanding R&D capabilities. Asia-Pacific is currently actively investing in developing its research capabilities and increasing its R&D competencies. Nations like South Korea, Japan, and China are engaged in developing modern laboratories and research capabilities, aiding improvements in synthetic biology. Moreover, funding and government initiatives are helping the market grow. government is supporting the market growth by funding programs, offering funding, subsidies, and more. These factors are helping the market grow considerably in the region.